The executive team at IO Biotech has a wealth of experience in the pharmaceutical and biotech industries, as well as in academia. Members of the team have led global clinical programmes at Boehringer Ingelheim, been medical directors at Genmab and Novo Nordisk, and held senior positions at Lundbeck, Azanta, and Genmab. The team also has experience in early-stage drug development, business development and strategy, and product portfolio strategy.
View all